| Not Yet Recruiting | CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors CAR-T Cell Therapy, Lymphomas | Phase 1 | 2024-12-01 |
| Recruiting | A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophospha Newly Diagnosed Diffuse Large B-cell Lymphoma | Phase 1 / Phase 2 | 2024-11-20 |
| Recruiting | "Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL NKTCL, Selinexor | Phase 1 / Phase 2 | 2024-09-01 |
| Unknown | A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Cent Primary Central Nervous System Lymphoma | Phase 1 / Phase 2 | 2021-03-29 |
| Unknown | Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central N Primary Central Nervous System Lymphoma | Phase 4 | 2019-09-05 |
| Unknown | PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma | Phase 4 | 2019-09-01 |
| Unknown | PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma NK/T Cell Lymphoma | Phase 4 | 2019-04-01 |
| Unknown | Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL ALK-Positive Anaplastic Large Cell Lymphoma | Phase 4 | 2018-10-01 |
| Unknown | A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma | Phase 4 | 2018-06-01 |
| Unknown | A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma T-lymphoblastic Lymphoma | Phase 4 | 2018-06-01 |
| Unknown | Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma Diffuse Large B Cell Lymphoma | Phase 4 | 2017-07-01 |
| Completed | Treatment of Primary CNS Lymphoma ( FTD ) Primary CNS Lymphoma (PCNSL) | Phase 2 | 2017-03-02 |
| Unknown | Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | 2017-02-19 |
| Unknown | A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma NK/T-Cell Lymphoma | Phase 4 | 2016-10-01 |
| Unknown | Treatment of Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma | Phase 4 | 2012-09-01 |
| Unknown | Treatment of Primary CNS Lymphoma Primary CNS Lymphoma (PCNSL) | Phase 4 | 2012-06-01 |
| Completed | Treatment of Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma | Phase 4 | 2011-08-01 |
| Unknown | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ Nasal and Nasal-type NK/T-cell Lymphoma | Phase 4 | 2011-01-01 |
| Unknown | Treatment of Natural Killer/T Cell Lymphoma-I/II Nasal and Nasal-type NK/T-cell Lymphoma | Phase 4 | 2011-01-01 |